Namestemovate E

Namestemovate E Uses, Dosage, Side Effects, Food Interaction and all others data.

Namestemovate E is under investigation for the treatment of Scleroderma. Namestemovate E has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids.

Trade Name Namestemovate E
Availability Prescription only
Generic Clobetasol
Clobetasol Other Names Clobetasol
Related Drugs Humira, Cosentyx, Dupixent, prednisone, doxycycline, methotrexate, betamethasone topical, Remicade, Stelara, cyclosporine
Type
Formula C22H28ClFO4
Weight Average: 410.907
Monoisotopic: 410.166015296
Groups Approved, Experimental, Investigational
Therapeutic Class
Manufacturer
Available Country United States
Last Updated: September 19, 2023 at 7:00 am
Namestemovate E
Namestemovate E

Innovators Monograph

You find simplified version here Namestemovate E

*** Taking medicines without doctor's advice can cause long-term problems.
Share